News | February 16, 2022
Moderna announces expansion in key Asian markets
New subsidiaries to be established in Malaysia, Taiwan, Singapore, and Hong Kong
New subsidiaries to be established in Malaysia, Taiwan, Singapore, and Hong Kong
Nuvaxovid is the first protein-based Covid-19 vaccine granted approval in South Korea
SK bioscience secures long-term license to supply the Novavax vaccine for the Korean market
The newest entrant from the company is the MOSS 1800F with an oxygen flow rate of 180 LPM or 10.8 Nm3/hour
Subscribe To Our Newsletter & Stay Updated
